Echoiq Limited · ASX:EIQ
Echoiq — ShareCafe Small Cap Hidden Gems Webinar 2021
13 slides from Echoiq's conference presentation, Oct 29, 2021
Slide 1: Investor Webinar Presentation (ASX release)
ASX: HWH RELEASE October 29, 2021 INVESTOR WEBINAR PRESENTATION Sydney: Predictive analytics and Artificial Intelligence company Houston We Have (the Company) (ASX:HWH) is pleased to announce its participation in the ShareCafe Small Cap "Hidden Gems" Webinar, to be held Friday 29th of October 2021 f
Slide 2: About Houston We Have / Investor enquiries
Investor enquiries: Andrew Grover, Executive Chair / Andrew.grover@echoiq.ai / +61 (0) 481 339 512 investor@HoustonWeHave.ai ABOUT Houston We Have (ASX: HWH) is a technology forward company that uses patented augmented intelligence software, data science and commercial insight to help organizations
Slide 3: ECHOiQ: reinventing cardiac diagnostics with AI
ECHOiQ Using the power of artificial intelligence to reinvent cardiac diagnostics ECHOiQ I HIDDEN GEMS WEBINAR OCTOBER 2021
Slide 4: Disclaimer & Forward Looking Statements
Disclaimer & Forward Looking Statements This presentation has been prepared by Houston We Have “HWH”. This document contains background information about HWH current at the date of this presentation, 6 September 2021. The presentation is in summary form and does not purport to be all inclusive or co
Slide 5: ECHOiQ: Corporate Snapshot
ECHOiQ Houston We Have: Corporate Snapshot Capital Structure (ASX: HWH) Share price (28 October 2021) $0.15 A company with a singular vision. Shares on issue 387,207,713 Options Issued 169,550,900 To reinvent cardiac diagnostics using Market Capitalisation $62M the power of AI. WHO WE ARE Net Cash B
Slide 6: Corporate Re-name
FROM: ECHOiQ TO: CORPOPRATE RE-NAME Re-branding our parent entity: AGM 29 November, 2021. Acquired by ASX-listed Houston We Have (HWH) in JuneReflective 2021 of our strategic focus and the commercial • opportunity we see. AI specialists with patented proprietary technology
Slide 7: What We Are Doing
Echocardiograms are commonly and ECHOiQ widely used. #1 Medicare line item. We are focused on the heart: WHAT WE ARE DOING Cardiovascular diseases kill 3 in 10 people worldwide. Developing applications that use Our first solution identifies patients existing clinical infrastructure and at-risk of Ao
Slide 8: Why Now
Research confirms Real advances in 1 widespread 2 Unique access to big data linked to 3 tech capability underdiagnosis mortality Technology enabled diagnostic ECHOiQ holds exclusive Machine learning, neural WHY NOW capability is increasing faster access to the world’s largest networks and other AI t
Slide 9: Access to Data
ECHOiQ has 17 years exclusive access to NEDA echocardiographic measurement data – the largest of its type (linked to mortality) worldwide. ACCESS TO DATA 1.0 2.0 3.0 4.0 NOW ACCESSING H1 2021 H2 2021 1,000,000 individuals In Development 330,000 650,000 > 200,000,000 2,000,000 individuals individuals
Slide 10: How ECHOiQ Works
Machine Learning Cutting edge Algorithm for an & AI applied to big + research in cardiac = AT-RISK profile of data from NEDA diagnostics key diseases HOW ECHOiQ WORKS ECHOiQ ESP – ENHANCED SCREENING PROGRAM MORE GUIDELINE RISK USABLE DATA DETECTION DETECTION +50% 100% +100%
Slide 11: Clinical Study
Clinical Study PHASE ECHOiQ Algorithm POC developed Partners: NEDA + Edwards LifeSciences 1 CLINICAL STUDY using machine learning, data science and imputation + St.Vincent’s Sydney Funding: Algorithm validation study on Study fully funded by Edwards 2 330,000 records successfully LifeSciences comple
Slide 12: Commercialisation
REPORTING COMMERCIALISATION HARWARE RETROSPECTIVE WORKFLOW INTEGRATION REVIEW INTEGRATION • Earliest opportunity • Extential partnership • Real-time guidance • Clinical Study > Review • Serves up an assessment • Sonographer’s aid • Identify additional patients • ECHOiQ “Button” • Additional measurem
Slide 13: ECHOiQ: Investor and media enquiries
ECHOiQ Using the power of ai to reinvent cardiac diagnostics Investor enquiries: Andrew Grover, Executive Chair / Andrew.grover@echoiq.ai investor@HoustonWeHave.ai Media enquiries: Media & Capital Partners Kristian Towse / Kris.Towse@mcpartners.com.au ECHOiQ I HIDDEN GEMS WEBINAR OCTOBER 2021
Houston We Have Ltd (ECHOiQ) — ShareCafe Small Cap Hidden Gems Webinar 2021 on 6ix